Record interest shown for Technoport 2017

Day 2 of Technoport was characterized by innovative startups, 'speed dates' and technology for the future. This year's conference set a new record for number of attendees, exhibitors and speakers.
Audience at Technoport 2017

“Care tech” triumphed at the Scale Up Challenge

The ScaleUp Challenge is a cooperation between Technoport, NVCA, Investinor, Abelia and FIN. The jury, consisting of amongst others Jon Øyvind Eriksen from Investinor, Terje Eidsmo of Proventures and Viking Venture’s Eivind Bergsmyr, had the pleasure of hearing the following startups pitch: AbleON, BlueEye Robotics, ReTyre, FutureHome, PeopleUknow, Simis AS, Concre3De, and JodaCare. 

JodaCare has developed a digital communication tool for next of kin and caretakers. Their aim is to increase quality of life for people suffering from dementia and those with disabilities, as well as to strengthen their relationship to their caretakers and next of kin. JodaCare needs 10 million NOK, to hire more developers and sales personnel. Today, they got one step closer to their goal.

Three startups were also given a free slot at Startups Sauna’s “Fast Track” accelerator: BlueEye, AbleON and ReTyre.

Live neurosurgery and 140 “speed dates”

During the second day of the conference Technoport attendees could had their pick of exciting lectures, workshops and panel debates. Among the events that drew the largest audience was the lecture “Surgery - Will the surgeon be redundant?”, where the audience had the chance to see a live broadcast of neurosurgery being performed at Trondheim’s St. Olav’s Hospital.

Like previous years, Technoport organized a “speed dating” event between investors and entrepreneurs, with 140 such dates occurring this year. In addition, Sweetzpot launched their crowdfunding campaign through, a platform for stock-based crowdfunding. Day t2 of the conference expo was dedicated to startups, and the attendees got to experience everything from drones, to tools for meditation and indoor-gardening.

Photo: Wil Lee-Wright

Share this page